期刊论文详细信息
Should Newer Oral Anticoagulants Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation and Risk Factors for Stroke or Thromboembolism? Newer Oral Anticoagulants Should Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation and Risk Factors for Stroke or Thromboembolism
Article
关键词: XA INHIBITOR EDOXABAN;    ANTITHROMBOTIC THERAPY;    COST-EFFECTIVENESS;    WARFARIN;    DABIGATRAN;    PHARMACODYNAMICS;    PHARMACOKINETICS;    TOLERABILITY;    CLOPIDOGREL;    ASPIRIN;   
DOI  :  10.1161/CIRCULATIONAHA.111.031146
来源: SCIE
【 授权许可】

Free   

  文献评价指标  
  下载次数:0次 浏览次数:0次